5th Feb 2020 7:00 am |
RNS |
MaxCyte to Present at BIO CEO & Investor Conf |
24th Jan 2020 4:31 pm |
RNS |
Grant Of Options |
22nd Jan 2020 5:15 pm |
RNS |
Holding(s) in Company |
22nd Jan 2020 5:11 pm |
RNS |
Holding(s) in Company |
22nd Jan 2020 5:08 pm |
RNS |
Holding(s) in Company |
20th Jan 2020 7:00 am |
RNS |
Trading Update |
19th Dec 2019 7:00 am |
RNS |
New Executive Vice President and Trial Update |
16th Dec 2019 5:25 pm |
RNS |
Director/PCA transaction initial notification |
4th Dec 2019 7:00 am |
RNS |
Agreement with KSQ Therapeutics |
21st Nov 2019 7:00 am |
RNS |
Vor Biopharma Clinical and Commercial License |
14th Nov 2019 7:00 am |
RNS |
Presentation at Jefferies Healthcare Conference |
7th Nov 2019 7:00 am |
RNS |
MaxCyte to Present at BIO-Europe 2019 |
1st Nov 2019 1:04 pm |
RNS |
Result of AGM |
24th Oct 2019 7:00 am |
RNS |
MaxCyte Advances Phase I Clinical Trial |
23rd Oct 2019 7:01 am |
RNS |
Presentations at Cell & Gene Therapy Congress |
8th Oct 2019 7:00 am |
RNS |
Notification of AGM and Audit Declaration |
7th Oct 2019 7:00 am |
RNS |
Editas Clinical and Commercial License Agreement |
30th Sep 2019 7:00 am |
RNS |
Updates on CARMA Platform at Upcoming Meetings |
18th Sep 2019 7:00 am |
RNS |
Results for the Six Months ended 30 June 2019 |
9th Sep 2019 7:00 am |
RNS |
Presentation at ICLE 2019 |
14th Aug 2019 7:00 am |
RNS |
Notice of Results |
17th Jul 2019 7:00 am |
RNS |
Trading Update |
11th Jul 2019 7:00 am |
RNS |
MaxCyte to Host Capital Markets Day Today |
5th Jul 2019 4:42 pm |
RNS |
Second Price Monitoring Extn |
5th Jul 2019 4:36 pm |
RNS |
Price Monitoring Extension |
19th Jun 2019 7:00 am |
RNS |
Annual Report |
12th Jun 2019 7:00 am |
RNS |
Appointment of Joint Corporate Broker |
29th May 2019 7:00 am |
RNS |
Save the Date: Capital Markets Day |
8th May 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
8th May 2019 4:36 pm |
RNS |
Price Monitoring Extension |
8th May 2019 7:00 am |
RNS |
Phase I Clinical Trial of MCY-M11 Progressed |
1st May 2019 7:00 am |
RNS |
ASGCT Presentation on First CARMA Drug Candidate |
24th Apr 2019 7:00 am |
RNS |
Final Results for Year Ended 31 December 2018 |
8th Apr 2019 7:00 am |
RNS |
Launch of ExPERTT Instrument Family |
26th Mar 2019 7:00 am |
RNS |
Notice of Full Year Results |
19th Mar 2019 5:05 pm |
RNS |
Director Dealings |
5th Mar 2019 7:00 am |
RNS |
Grant of Options |
1st Mar 2019 7:00 am |
RNS |
Clinical & Commercial Agreement with Kite |
26th Feb 2019 5:32 pm |
RNS |
Result of Special Meeting and Issue of Equity |
5th Feb 2019 4:32 pm |
RNS |
Results of Placing |